AI-generated summary
The authors report a randomized trial of 53 patients with head and neck cancer, comparing photobiomodulation therapy plus artificial saliva against sham laser plus artificial saliva. The PBM-T group showed improved xerostomia-related quality of life and lower oral mucositis grades than the sham group, with no significant difference in dental or periodontal measures.
- Participants
- 53
- Who or what was studied
- Patients with head and neck squamous cell carcinoma
- Limits stated in the abstract
- The abstract does not state the laser wavelength, dose or blinding details, and it does not report the sample size per group or follow-up duration.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Sham, Photobiomodulation therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.